4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-064254
President and CEO sold 16,381 shares at $13.62 ($223,109)
From the SEC's structured data for this filing
Trades in this filing
AHMED NADIM · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-20 | Sale : show line 1 in the form | −16,381 | $13.62 | $223,109 | 404,318 | D |
| Open-market sales · 16,381 sh · avg $13.62 · $223,109 | ||||||
Loading xslF345X05/ownership.xml…